Your Partner for Gastroenterology Clinical Trial Management

Patient Recruitment

Recruitment for GI trials often requires navigating symptom variability, patient embarrassment, or competing therapeutic options. We understand how these barriers affect enrollment timelines.

Our pre-screened database includes over 19,000 engaged participants, and we have access to more than 500,000 patient charts through our healthcare partners. Many of these patients are motivated by persistent symptoms, limited therapeutic options, or a desire to contribute to medical advancement. We supplement this with targeted recruitment strategies that efficiently reach prospective participants, achieving a nearly 37% diversity rate aligned with FDA inclusivity goals.

We also benefit from a strong referral pipeline through Dr. Krishna Rayapudi, our investigator in gastroenterology. His active clinical practice, located just six miles away in Hilliard, Ohio, provides a steady flow of patients across GI conditions, accelerating enrollment for targeted trials. Because Dr. Rayapudi also owns the endoscopy center, we have unparalleled scheduling flexibility—including after-hours and weekend procedures—which increases patient compliance, improves retention, and ensures procedures remain within protocol windows.

Patient Management

At RDI, patient retention starts from day one, and our 97% retention rate across all studies proves our commitment to patient-centered care.

In gastroenterology, where conditions like ulcerative colitis or IBS can affect a patient’s quality of life and daily functioning, providing both medical and emotional support is a must. We offer no-cost transportation, flexible visit scheduling, and a welcoming, low-stress environment. Our team delivers clear communication, patient education, and prompt follow-up to help participants stay engaged throughout the trial.

Participants often choose to return for additional GI studies, underscoring the trust and care they experience at our site.

Data Collection

Accurate, real-time data capture is foundational to quality GI research. Whether capturing symptom diaries, stool assessments, or endoscopic evaluations, we follow rigorous protocols to maintain consistency and completeness.

All clinical data is entered into our EDC platform the same day it’s collected. Sponsors benefit from timely access to site performance metrics and remote monitoring capabilities that streamline oversight and reduce delays.

Regulatory Compliance

Gastroenterology trials frequently involve complex biologics or advanced oral therapies that demand tight protocol adherence and thorough safety monitoring.

At RDI, we operate under strict ICH-GCP and FDA regulatory standards from study start-up to close-out. Our seasoned staff ensures precise documentation, efficient IRB communication, and seamless coordination with sponsor and CRO teams. We remain especially vigilant about the unique safety profiles and administration routes common in GI trials.

This proactive, detail-centric approach protects patient safety and data integrity, keeping you audit-ready at every phase.